EP 4021912 A4 20230823 - PRODRUGS OF THE TYROSINE KINASE INHIBITOR FOR TREATING CANCER
Title (en)
PRODRUGS OF THE TYROSINE KINASE INHIBITOR FOR TREATING CANCER
Title (de)
PRODRUGS DES TYROSINKINASEINHIBITORS ZUR BEHANDLUNG VON KREBS
Title (fr)
PROMÉDICAMENTS DE L'INHIBITEUR DE TYROSINE KINASE POUR LE TRAITEMENT DU CANCER
Publication
Application
Priority
- CN 201910817505 A 20190830
- CN 201910818675 A 20190830
- CN 201910818779 A 20190830
- US 202062994364 P 20200325
- CA 2020051177 W 20200828
Abstract (en)
[origin: WO2021035360A1] There are provided compounds of Formula (I), and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, useful for inhibition or modulation of the activity of tyrosine kinases and treatment of disease states or conditions mediated by tyrosine kinases, including cancers. (I)
IPC 8 full level
C07F 9/6558 (2006.01); A61K 31/4439 (2006.01); A61K 31/675 (2006.01); A61P 35/00 (2006.01); C07D 401/06 (2006.01); C07D 401/14 (2006.01); C07D 405/12 (2006.01)
CPC (source: EP IL)
A61P 35/00 (2017.12 - EP IL); C07D 401/06 (2013.01 - EP IL); C07D 401/14 (2013.01 - EP IL); C07D 405/12 (2013.01 - EP IL); C07F 9/65583 (2013.01 - EP IL); Y02P 20/55 (2015.11 - EP)
Citation (search report)
- [XI] CN 106317017 A 20170111 - LI JIANCHENG
- See references of WO 2021035360A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2021035360 A1 20210304; AU 2020338490 A1 20220317; CA 3147801 A1 20210304; EP 4021912 A1 20220706; EP 4021912 A4 20230823; IL 290798 A 20220401
DOCDB simple family (application)
CA 2020051177 W 20200828; AU 2020338490 A 20200828; CA 3147801 A 20200828; EP 20857153 A 20200828; IL 29079822 A 20220222